Our results suggest that UHF 1H MRS could be useful as a prognostic precision medicine biomarker detection system for identifying, stratifying, and monitoring IDH1 and IDH2 mutant glioma patients towards the goal of precision medicine of gliomas. This evidence concerns the gene IDH2 and glioma.